DexCom

Recent news

• Company notice
  DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.
  SEC · 2025/10/29
• Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $102
  Market Newswire · 2026/9/24
• Company notice
  DexCom | 4: Statement of changes in beneficial ownership of securities-Director Ashley Euan A.
  SEC · 2026/6/2
• Rating change
  Citi Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $105
  Market Newswire · 2026/8/14
• Rating change
  UBS Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96
  Market Newswire · 2026/7/29
• Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $102
  Market Newswire · 2026/9/18
• Rating change
  A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $82 to $105
  Market Newswire · 2026/7/31
• Company notice
  DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.4%)
  SEC · 2024/12/7
• TD Cowen Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95
  Market Newswire · 2026/9/18
• Rating change
  Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $90
  Market Newswire · 2026/7/15
• Rating change
  Truist Financial Maintains DexCom(DXCM.US) With Buy Rating, Announces Target Price $87
  Market Newswire · 2026/7/16
• Rating change
  Mizuho Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $95
  Market Newswire · 2026/8/4
• Rating change
  RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/7/14
• Company notice
  DexCom | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.5%)
  SEC · 2024/1/26
• Rating change
  A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $82 to $94
  Market Newswire · 2026/8/1
• Company notice
  DexCom | 3: Initial statement of beneficial ownership of securities-Director Ashley Euan A.
  SEC · 2025/10/29
• Rating change
  Argus Research Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $96
  Market Newswire · 2026/8/4
• Rating change
  CCORF Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $90
  Market Newswire · 2026/8/3
• Citi Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105
  Market Newswire · 2026/8/14
• Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
  Market Newswire · 2026/9/30

Headlines are aggregated automatically and are not independently verified or edited by our team.